首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Original quinazoline derivatives displaying antiplasmodial properties.
【24h】

Original quinazoline derivatives displaying antiplasmodial properties.

机译:原始喹唑啉衍生物具有抗血浆特性。

获取原文
获取原文并翻译 | 示例
           

摘要

The multistep synthesis of new quinazoline-derived molecules and their in vitro antiplasmodial evaluation on the W2 chloroquino-resistant Plasmodium falciparum strain is described herein. These molecules have also been studied concerning their in vitro cytotoxicity toward two human cell lines (K652 and HepG2) in order to calculate their respective selectivity indexes (S.I.). Among the fourteen tested molecules, two exhibited both significant antiplasmodial activity (IC(50)=0.95 and 1.3 microM) and low toxicity (IC(50)>100 or 125 microM), compared with two reference drugs: chloroquine and doxycycline. The structure activity relationships establish that the molecular scaffold which exerts the best profile is the 6-nitro-2-(tosylmethyl)-N-(3-substituted-phenyl)-quinazolin-4-amine. The hit molecules were finally investigated regarding their potential action toward two other protozoa, Leishmania donovani and Toxoplasma gondii, showing that these molecules display a selective antiplasmodial activity.
机译:本文描述了新的喹唑啉衍生的分子的多步合成及其在耐W2氯喹诺酮的恶性疟原虫菌株上的体外抗血浆评价。还已经研究了这些分子关于它们对两种人细胞系(K652和HepG2)的体外细胞毒性,以便计算它们各自的选择性指数(S.I.)。与两种参比药物:氯喹和强力霉素相比,在这14种受测分子中,两种分子均显示出显着的抗血浆活性(IC(50)= 0.95和1.3 microM)和低毒性(IC(50)> 100或125 microM)。结构活性关系确定发挥最佳轮廓的分子支架是6-硝基-2-(甲苯磺酰基甲基)-N-(3-取代的苯基)-喹唑啉-4-胺。最后研究了这些命中分子对另外两个原生动物利什曼原虫和弓形虫的潜在作用,表明这些分子显示出选择性的抗疟原虫活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号